Search This Blog

Tuesday, May 7, 2019

Eidos Therapeutics reports Q1 EPS (32c), consensus (31c)

Cash and cash equivalents totaled $at March 31, compared with $157.1M at December 31, 2018.
https://thefly.com/landingPageNews.php?id=2905239
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)